Invivyd
Anna Holmes is a Senior Clinical Scientist at Invivyd with previous experience at Galderma. Anna has a Ph.D. in Microbiology and Immunology from the University of North Carolina at Chapel Hill School of Medicine. Anna has expertise in managing clinical protocols, coordinating study teams, and disseminating scientific information to healthcare professionals. Anna has a background in vaccine research and has made significant contributions in developing effective vaccines against norovirus.
This person is not in any offices
Invivyd
2 followers
Invivyd is a clinical-stage a biotechnology company developing best-in-class antibodies that can broadly neutralize SARS-CoV-2, SARS-CoV-1 and additional pre-emergent coronaviruses.